Gary Brecka

And the average time to develop

has been five to eight years.

Well, we cut the R&D costs in half and we cut the time in half.

And so we're going to see a lot more generic versions.

We want to move more drugs to over the counter.

Why do you need a prescription for naloxone?

Right?

Who are we protecting?

Yeah, who's going to abuse that, by the way?

Yeah, right.

Who's going to abuse it?

If there's no abuse potential, if it's safe, if it's something that people can figure out with, they can have a discussion with their doctor and decide, hey, this may benefit you.

And they're not going to abuse it for the creation of something else in society.

and you don't need laboratory tests to monitor, say, your liver function when you start a drug, then what are we doing?

What are we doing?

So we want to get more drugs to over-the-counter.

So that's where you can widen some of these lanes.

Yeah, you can.

And also, when a drug's over-the-counter, now it's got a price on the shelf of the pharmacy because you're picking it up.

And now there's price competition.